The Low Expression of Fc-Gamma Receptor III (CD16) and High Expression of Fc-Gamma Receptor I (CD64) on Neutrophil Granulocytes Mark Severe COVID-19 Pneumonia.

Hoffmann, Joerg; Etati, Rojin; Brendel, Cornelia; Neubauer, Andreas; Mack, Elisabeth

Hoffmann, Joerg; Etati, Rojin; Brendel, Cornelia; Neubauer, Andreas; Mack, Elisabeth.

Afiliación

Hoffmann J; Department of Hematology, Oncology and Immunology, University Hospital Giessen and Marburg, Philipps University Marburg, Baldingerstrasse, D-35043 Marburg, Germany.
Etati R; Department of Hematology, Oncology and Immunology, University Hospital Giessen and Marburg, Philipps University Marburg, Baldingerstrasse, D-35043 Marburg, Germany.
Brendel C; Department of Hematology, Oncology and Immunology, University Hospital Giessen and Marburg, Philipps University Marburg, Baldingerstrasse, D-35043 Marburg, Germany.
Neubauer A; Department of Hematology, Oncology and Immunology, University Hospital Giessen and Marburg, Philipps University Marburg, Baldingerstrasse, D-35043 Marburg, Germany.
Mack E; Department of Hematology, Oncology and Immunology, University Hospital Giessen and Marburg, Philipps University Marburg, Baldingerstrasse, D-35043 Marburg, Germany.

Diagnostics (Basel) ; 12(8)2022 Aug 19.

Article en En | MEDLINE | ID: mdl-36010361

Palabras clave

CD16; CD64; COVID-19; Fc-gamma receptor; corona; flow cytometry; pneumonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Diagnostics (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google